scholarly journals PDB32 A LONG-TERM Cost-Effectiveness Analysis of Treatments for Type 2 Diabetes in Portugal: Once-Weekly Semaglutide 1 MG Versus Once-Daily Empagliflozin 25 MG

2020 ◽  
Vol 23 ◽  
pp. S511
Author(s):  
N. Hallén ◽  
D. Carvalho ◽  
C. Costa ◽  
B. Hunt
Keyword(s):  
Type 2 Diabetes ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Once Daily ◽  
Effectiveness Analysis

scholarly journals Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia

2018 ◽  
Vol 10 (1) ◽  
pp. 159-176 ◽  
Author(s):  
Samuel J. P. Malkin ◽  
Monika Russel-Szymczyk ◽  
Girtel Liidemann ◽  
Vallo Volke ◽  
Barnaby Hunt
Keyword(s):  
Type 2 Diabetes ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Once Daily ◽  
Effectiveness Analysis

Switching from sitagliptin to liraglutide to manage patients with type 2 diabetes in the UK: A long-term cost-effectiveness analysis

2018 ◽  
Vol 20 (8) ◽  
pp. 1921-1927 ◽  
Author(s):  
Anthony H. Barnett ◽  
Simon Arnoldini ◽  
Barnaby Hunt ◽  
Gowri Subramanian ◽  
Christina Stentoft Hoxer
Keyword(s):  
Type 2 Diabetes ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
The Uk

scholarly journals The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia

2019 ◽  
Vol 36 (8) ◽  
pp. 2034-2051 ◽  
Author(s):  
Samuel J. P. Malkin ◽  
Monika Russel-Szymczyk ◽  
Marek Psota ◽  
Lucia Hlavinkova ◽  
Barnaby Hunt
Keyword(s):  
Type 2 Diabetes ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis
Sign in / Sign up

Export Citation Format

Share Document